• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[이데일리] 단1회 투입으로 2개월만 말기암 완치 ‘기적의 신약’

2020/10/13

단1회 투입으로 2개월만 말기암 완치 ‘기적의 신약’ (edaily.co.kr)

이데일리 류성 기자

Prev[서울경제] [주목!바이오벤처-큐로셀] “고형암도 치료 가능한 CAR-T…연내 임상 시작”
Next[한경 BIO Insight] [Cover Story – part.5] 큐로셀, CAR-T 뛰어넘는 CAR-T 개발
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.